SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations

SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations is a high-purity cyclodextrin derivative widely used in parenteral pharmaceutical applications. Designed to improve solubility and stability, Betadex Sulfobutyl Ether Sodium enhances the bioavailability of poorly soluble active pharmaceutical ingredients (APIs) in injectable drugs. Its excellent inclusion complex formation ensures that APIs remain stable and evenly distributed throughout the solution, providing reliable therapeutic performance.

This excipient is suitable for intravenous, intramuscular, and subcutaneous formulations. By preventing precipitation, controlling aggregation, and improving chemical stability, SBECD ensures the safety and efficacy of injectable medications. It is also compatible with sensitive liquid formulations such as ophthalmic solutions and nasal sprays, where stability and solubility are critical.

With over 26 years of experience since 1999, our company has been providing SBECD (Betadex Sulfobutyl Ether Sodium) with consistent quality, high purity, and reliable performance. Each batch undergoes rigorous quality control to ensure uniformity, making it ideal for research, clinical development, and commercial production of injectable drugs.

We also provide technical data, certificates of analysis (COA), and samples for evaluation, helping formulators optimize their injectable drug products. With its low toxicity, biocompatibility, and high solubility, SBECD remains a preferred choice for stable and effective injectable formulations worldwide.

SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations

CAS NO: 182410-00-0

Molecular formula: C42H70-nO35·(C4H8SO3Na)n

Grade: Injection grade

Executive standard: USP/EP/Enterprise standard

Specification: 500g/Bag; 1kg/Bag; 10kg/bag; 10kg/drum.